CA Stock MarketDetailed Quotes

Apotex Health Corp (APTX)

Watchlist

33.190
-0.680-2.01%

15min DelayMarket Closed Aug 24 16:00 ET

7.58BMarket Cap-278.91P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Apotex Health Corp (APTX) Income Statement

Quarterly·All

YOY

Hide blank lines

Currency: CAD

2027/Q1

2026/Q1

Total Revenue as Reported

-25.76%847.98M

--1.14B

Total Operating Revenue

-25.76%847.98M

--1.14B

Cost of Revenue

+6.72%426.77M

--399.89M

Gross Profit

-43.26%421.21M

--742.40M

Operating Expense

+42.75%334.56M

--234.36M

Selling and Admin Expenses

+59.80%253.72M

--158.77M

Research & Development

+2.06%38.98M

--38.19M

Other Operating Expenses

+11.95%41.87M

--37.40M

Operating Profit

-82.94%86.65M

--508.04M

Net Non-Operating Interest Income (Expense)

-12.98%-57.31M

---50.72M

Non-Operating Interest Income

-22.73%1.02M

--1.32M

Non-Operating Interest Expense

+17.77%54.81M

--46.54M

Total Other Finance Costs

-36.01%3.53M

--5.51M

Other Income (Expense)

-2181.09%-42.48M

--2.04M

Gain on Sale of Security

-200.81%-22.80M

--22.62M

Special Income (Charges)

+4.36%-19.68M

---20.57M

-Less:Restructuring and Mergern & Acquisition

-81.93%3.11M

--17.22M

-Less:Impairment of Capital Assets

--5.84M

--0.00

-Less:Other Special Charges

+220.17%10.73M

--3.35M

Pretax Profit

-102.86%-13.13M

--459.36M

Tax

-73.91%25.21M

--96.66M

Net Profit

-110.57%-38.35M

--362.70M

Profit from Continuing Operations

-110.57%-38.35M

--362.70M

Net Income to Parent Company

-110.57%-38.35M

--362.70M

Net Income to Common Stockholders

-110.57%-38.35M

--362.70M

Basic EPS

-111.97%-0.19

--1.59

Diluted EPS

-111.97%-0.19

--1.59

Deadline

Jun 30, 2026

Jun 30, 2025

Accounting Standard

US_GAAP

	2027/Q1	2026/Q1

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.